Abstract. Attachment and neurite extension have been measured when Platt or La-N1 human neuroblastoma cells respond to tissue culture substrata coated with a panel of complementary fragments from the individual chains of human plasma (pFN) or cellular fibronectins (cFN) purified from thermolysin digests. A ll0-kD fragment (riD), which contains the Arg-Gly-Asp-Ser sequence (RGDS)-dependent cell-binding domain but no heparin-binding domains and whose sequences are shared in common by both the Qt-and 13-subunits of pFN, facilitated attachment of cells that approached the level observed with either intact pFN or the heparan sulfate-binding platelet factor-4 (PF4). This attachment on ill0 was resistant to RGDS-containing peptide in the medium. Neurite outgrowth was also maximal on fll0, and half of these neurites were also resistant to soluble RGDS peptide. Treatment of cells with glycosaminoglycan lyases failed to alter these responses on fll0. Therefore, there is a second "cell-binding" domain in the sequences represented by ill0 that is not RGDS-or heparan sulfate-dependent and that facilitates stable attachment and some neurite outgrowth; this domain appears to be conformation-dependent.
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Comparisons were also made between two larger fragments generated from the two subunits of pFN-f145 from the ~t-subunit and f155 from the 13-subunit-both of which contain the RGDS-dependent cell-binding domain and the COOH-terminal heparinbinding domain but which differ in the former's containing some IIICS sequence at its COOH terminus and the latter's having an additional type III homology unit. Heparin-binding fragments (with no RGDS activity) of I29 and f38, derived from f145 or f155 of pFN, respectively, and having the same differences in sequence, were also compared with f44+47 having the "extra domaina" characteristic of cFN. Attachment on fl45 was slightly sensitive to soluble RGDS peptide; attachment on fl55 was much more sensitive. There were also differences in the percentage of cells with neurites on fl45 vs. fl55 but neurites on either fragment were completely sensitive to RGDS peptide. Mixing of f29, t38, or PF4 with ill0 could not reconstitute the activities demonstrated in f145 or fl55, demonstrating that covalently linked sequences are critical in modulating these responses. However, mixing of f44+47 from cFN with ill0 from pFN increased the sensitivity to RGDS peptide. Attachment on f29 was poor, on f44+47 intermediate, and on 138 or PF4 very good, demonstrating the modulation of responses by the additional type III homology unit (in t38) and by alternately spliced sequences represented in the "extra domain" (in f44+47). The COOHterminal heparin-binding domain appears to modulate RGDS-dependent cell-binding activity as well (by comparing fll0 with either fl45 or f155): (a) better attachment on ill0; (b) resistance of attachment on fll0 to RGDS peptide; (c) higher percentage of cells with neurites on fll0 and their resistance to RGDS peptide; and (d) increased resistance of attachment on f155 when cells were treated with heparitanase. These data suggest that the responses of human neuroblastoma cells are mediated by two different cell-binding domains, as well as by the heparan sulfate-binding domain. Furthermore, the cell-binding responses can be modulated in four different ways: by neighboring sequences found in the IIICS region of pFN or cFN, by "extradomaina," by the additional type III homology unit in the 13-subunit of pFN, and by the COOHterminal heparan sulfate-binding domain.
T hE mechanisms by which specific neuronal subpopulations in animals adhere and react to fibronectin-conraining extracellular matrices are being resolved with a variety of experimental approaches in tissue culture model systems. Chick embryonic retinal neurons adhere and extend neurites on fibronectin-coated tissue culture substrata in chemically defined medium (1) . The same applies to chick dorsal root and sympathetic neurons (39) , as well as to neurons from rat superior cervical ganglia (41) . In the case of chick sympathetic neurons that also respond effectively to laminin-coated substrata, neurite outgrowth is promoted by the heparan sulfate-binding domain of this molecule and not by its cell-binding domain (16) . In similar experiments, chick dorsal root ganglia have been shown to extend neurites effectively on substrata coated with the tetravalent heparan sulfate-binding protein, platelet factor-4 (PF4) ~ (Chernoff, E. A., S. L. Tobey, and L. A. Culp, unpublished data; 15) . Cell surface heparan sulfate proteoglycan interacts with a 170K glycoprotein to mediate some responses of chick neural retina cells (13) , and heparan sulfate proteogtycan has been localized at the basal lamina interface with peripherai neurons of various sorts in vivo (5, 17) .
Neuroblastoma tumor ceils from rodents or humans share a common origin with peripheral neurons from the neural crest of the developing embryo and also effective adherence and neurite outgrowth on fibronectin-coated substrata (4, 12, 14, 38, 40) . Therefore, these tumor cells because of ease of clonal growth and metabolic/biochemical analyses can be used as a partial model for the molecular mechanisms of interaction of neurons with extracellular matrices, with the caveat that these cells have been exposed to some unique selection pressures during tumor progression. The same applies to a peripheral neural tumor, PC12, which also requires nerve growth factor for neurite development (2) . However, the mechanisms of neurite outgrowth of neuroblastoma cells on human plasma fibronectin (pFN) have recently been shown to have different molecular bases (15, 46) . Human and rat neuroblastoma cells adhere and spread in a pseudopodiatlike fashion on PF4-coated substrata, consistent with the high concentrations of heparan sulfate proteoglycans in their substratum adhesion sites (14, 29, 47a) , but fail to extend neurites on PF4 under the very same conditions that chick dorsal root neurons do (46) . In contrast, several cell-binding fragments of pFN lacking heparin-binding activity display neurite-promoting activity with primary peripheral neurons from the chick (40) , and neuroblastoma cells extend neurites on a chymotrypsin-generated 120K cell-binding fragment of pFN (46) . The neurite-generating activity of this fragment has been shown to depend only on the Arg-Gly-Asp-Ser sequence (RGDS) contained within this fragment (48), a sequence recognized by a 140K glycoprotein complex on the surface of many cell types (3, 9, 11, 19, 36, 37) . There is a different glycoprotein complex (l15K/150K) on the surface of some cells which acts as a receptor for the vitronectin molecule and which also recognizes an RGDS sequence (44) . Furthermore, testing of neurite outgrowth of neuroblastoma cells on substrata coated with intact pFN molecules with soluble RGDS peptides has revealed a second "cell-binding" activity in the intact pFN, which is completely insensitive to inhibition and independent of heparan sulfate binding (48) . A third mechanism of neurite outgrowth with these cells is I. Abbre~ations used in this paper: cFN, cellular fibronectin; EDa, extra domain; GAG, glycosaminoglycan; PF4, platelet factor-4; pFN, plasma fibronectin; REDV, Arg-Glu-Asp-Val; RGDS, Arg-Gly-Asp-Ser. mediated by a cell surface ganglioside (45) , which acts cooperatively with an unidentified cell surface protein when these ceils adhere to an appropriate ganglioside-binding substratum (31) . Therefore, these neural crest-derived tumor cells have evolved multiple and alternative mechanisms by which they adhere and extend differentiated processes on a fibronectin-coated matrix. This system becomes particularly valuable for studying the molecular bases for this "differentiation" process and for resolving the multiple binding activities in the fibronectins responsible.
To pursue the latter objective, fragments of human plasma or cellular fibronectins (cFN) that have overlapping permutations of the known binding domains of these molecules (30, 40, 49) were tested. Chick embryonic peripheral neurons were observed to generate neurites effectively on fibronectin fragments containing either the COOH-terminal heparinbinding domain or a cell-binding domain (40) . Since both pFN and cFN are composed of more than one polypeptide generated by alternative splicing mechanisms of a common pre-messenger RNA, as discovered in both protein biochemical analyses (7, 34, 43) and in gene structure/expression studies (21, 25) , it would be optimal to examine specific regions of individual fibronectin polypeptides. This possibility became feasible with the scheme developed by Zardi and his colleagues (8, 10, 33) for isolating sequences from the two different pFN 0t-and 13-subunits, which differ in the amounts of the alternately spliced IIICS region of the molecule (21) , and sequences from the alternately spliced "extra domain" (EDa) (21) region characteristic of the cellular fibronectins. In the studies reported here, the adherence and neurite outgrowth properties of two human neuroblastoma cells have been measured on substrata coated with these various fragments for comparison with the intact fibronectins and with heparan sulfate-binding PF4. Sensitivity to inhibition with an RGDS-containing peptide and/or with pretreatment of the cell with specific glycosaminoglycan (GAG) lyases, in order to test the contribution of a recently discovered cryptic GAG-binding domain (28) , has been used to discriminate and further characterize the multiple mechanisms of adherence and neurite outgrowth on the fibronectins.
Materials and Methods

Cell Culture
Two human neurohlastoma cell lines, Platt (12) and La-NI (46), were grown Mycoplasma-free as stock cultures in DME, supplemented with 10% neonatal calf serum, 250 U/ml penicillin, and 250 gg/ml streptomycin sulfate at 37~ in a 10% COJhumidified air mixture. Both cell lines were from advanced tumors whose cells contained a 50-100-fold amplification of the N-myc oncogene (48) . In select cases, cells were supplemented with highly purified gangliosides by established procedures (23, 3t) . Briefly, subconfluent cultures after 48 h of growth were exposed to 50 p.M purified ganglioside in DME containing 1% neonatal calf serum for 24 h; cells grew continuously in this medium and biochemical analyses of the ganglioside fractions of cells using thin-layer chromatography methods demonstrated the incorporation of the particular ganglioside into the membrane fraction (data not shown).
Binding Proteins and Their Fragments
pFN was purified from blood bank plasma by gelatin-Sepharose affinity chromatography (18) and stored at -85~ in CAPS buffer (0.15 M NaCI, 1.0 mM CaCl2, 10 mM 3-cyclohexylamino-l-propane sulfonic acid; pH 11.0). Human PF4 was purified from outdated platelet packs obtained from
The Journal of Ceil Biology, Volume 106, 1988the Cleveland Red Cross by heparin-Sepharose affinity chromatography (26) , was completely free of contamination with pFN, and was stored in PBS supplemented with 0.2 M NaCI at -85~ A variety of purified fragments of human plasma or cellular fibronectins (cFN) were generated as described by Zardi and his collaborators (8, t0, 28, 33) . Fibronectins were treated with thermolysin and then specific fragments purified by sequential affinity chromatography on columns of gelatinSepharose or heparin-Sepharose, or supplementally with a column derivatized with one of a variety of monoclonal antibodies whose epitopes had been mapped. The following fragments are used as described more completely in references 8 and 10 and in Fig. 1 : llOK fragment (ill0) from pFN contains the RGDS-dependent cell-binding domain (9, 11, 19, 37) and an RGDS-independent cell-binding activity (48) but no COOH-terminal heparin-binding domain; 145K fragment (fl45) from the ct-subunit of pFN contains all of the sequence of ill0 plus a region that includes the COOHterminal heparin-binding domain and some IIICS sequence at its C-terminus; 155K fragment (fl55) from the 13-subunit of pFN contains all of the sequence of fllO plus a larger region containing the COOH-terminal ,heparin-binding domain and an additional type III homology unit; 29K fragment (129) from the r of pFN contains the COOH-terminal heparinbinding domain and some IIICS sequence but no RGDS-dependent or independent cell-binding domains; 38K fragment (t38) from the [I-subunit of pFN contains the COOH-terminal heparin-binding domain but no cellbinding domains and an additional type III homology unit (this fragment is derived from cleavage of fl55); a mixture of 44K and 47K fragments from cFN(f44+47) contains the COOH-terminal heparin-binding domain and one of the "extra domains" (EDa) attributed to cellular fibronectins, but no cell-binding domains (Fig. 1) .
Adhesion Assays
For all experiments, the stock cultures were rinsed twice with PBS and then fed 0.5 mM EGTA in PBS for shaking at 37~ for 30 min (31, 46, 48) . The detached cells were pelleted by centrifugation, rinsed twice in PBS by recentrifugation, and suspended in adhesion medium (serum-free DME plus 250 ~g/ml heat-treated BSA). Meanwhile, tissue culture plastic cluster wells (48-well dishes) or glass coverslips in select cases were coated with 20 ~g/ml of the proteins being tested in protein-free DME for 1 h at 37~ the wells were rinsed twice with PBS containing 1 mM MgCl2 and 1 mM CaCl2 and then re-fed with 200 ~1 of adhesion medium.
To quantitate the attachment of cells on substrata coated with various proteins, stock cultures were radiolabeled during 48 h of exponential growth in medium containing 0.5 p.Ci/ml of [methyl-3H]thymidine (sp. act. 10-20 Ci/mmol); these radiolabeling conditions did not inhibit the growth or neurite extension of cells. Unlabeled medium was added for an additional 24 h before subculturing into experimental wells (as described above). Aliquots of cells (2 x 104) were inoculated into wells, which were incubated for 1 h at 37~ to evaluate attachment as follows. The medium was aspirated off and the adherent cells rinsed twice with PBS containing divalent cations; the cells were then solubilized with 50 p.l (for 96-well plates) of 1% SDS in 0.1 N NaOH for 1 h. Radioactive solubilized cells were quantitated by scintillation counting with correction for quenching and compared on percent bases with values of the original cell suspension.
For phase-contrast microscopy of cell adherence and neurite outgrowth, stock cultures were not radiolabeled. In most cases, plastic tissue culture cluster wells were used and, where noted, glass coverslips were also used with identical results. The cells were allowed to attach and spread over an 18-h period before glutaraldehyde fixation and photography on a Nikon Diaphot phase-contrast microscope. Photographs of these fields were used to quantitate neurite outgrowth as described previously for cell processes that were longer than one cell body diameter (12, 31, 46) ; statistical signifcance was determined with a Student's t-test.
Peptides A and B
To evaluate the contribution of the RGDS sequence in the fibronectins as a cell-binding activity (36) known to promote attachment and neurite outgrowth of these cells (46, 48) , two peptides were tested as soluble inhibitors of cell responses. Peptide A (Gly-Arg-Gly-Asp-Ser-Pro-Cys) and peptide B as the control (Gly-Arg-Gly-Glu-Ser-Pro) were synthesized to specifications by Peninsula Laboratories (Belmont, CA) and purified by high pressure liquid chromatography. None of the effects of peptide A reported here could be attributed to the COOH-terminal cysteine residue (data not shown). The effectiveness of peptide A was further verified by demonstrating complete inhibition of attachment of BALB/c 3T3 cells at concentrations >100 p.g/ml. Figure 1 . Origin of fragments from the two chains of human plasma fibronectins or the multiple chains of cellular fibronectins. Products of thermolysin digestion o f p F N are shown with the larger t"145 and fl55 chains liberated initially from the a-and 13-subunits, respectively. There are two regions of sequence difference in these fragments: some IIICS-derived amino acids at the C O O H terminus of fl45 (IIICS) but not in f155, which lacks a IIICS region, and an additional type III homology unit (identified with a +) at the COOH terminus of fl55. Otherwise, these two fragments both contain the RGDS-dependent cell-binding domain (Cello and the COOH-terminal heparin-binding domain (Hepn). (They also may contain a second cell-binding domain [Cell~i] as explained in the text which is RGDS independent, although its location is still undefined; it is likely that this domain results from the conformational folding of the protein to bring two distant sequences together.) F145 is subsequently cleaved to give rise to fll0 and f29, which separates the RGDS-dependent cell-binding domain from the COOH-terminal heparin-binding domain into the respective fragments. F155 is cleaved to give rise to the same fll0 fragment, as well as f38 with its additional type III homology unit. Cellular FNs go through a similar cleavage sequence to give rise to two sets of fragments (f44+47), which contain the "extra domain" (EDa) characteristic of cFNs, the Hepll domain, and some IIICS sequence at the C O O H terminus.
GAG Lyase Treatment of Cells
These treatments were as described by Laterra et al. (27) . Briefly, EGTAdetached cells ([3H]thymidine-radiolabeled to quantitate attachment) were rinsed twice in PBS plus divalent cations and treated in suspension with either 0.1 U/ml chondroitinase ABC/1 • 106 cells or 0.02 U/ml Flavobacterium heparitanase in PBS supplemented with divalent cations and 2 mg/ml BSA for 1 h with constant agitation at 37~ then a second dose of enzyme was added for an additional 0.5-1 h. Viability of cells after the enzyme treatments was routinely >93% when compared with untreated control cells. Control or enzyme-treated cells were then inoculated into wells containing adhesion medium and in some cases peptide A or B.
Materials
BSA, EGTA, heparin, and gelatin were purchased from Sigma Chemical Co., St. Louis, MO; Sepharose 4B from Pharmacia Fine Chemicals, Piscaraway, N J; 48-well cluster dishes from Costar, Cambridge, MA; neonatal calf serum from Biologos, Naperville, IL; [methyl-3H]thymidine from Amersham Corp., Arlington Heights, IL; chondroitinase ABC from Miles Biochemicals, Elkhart, IN; and glutaraldehyde (50% wt/wt) and technical pan films from Eastman Kodak Co., Rochester, NY. Flavobacterium heparinum heparitanase was kindly provided by Dr. Jeremiah Silbert of Boston's Veterans Administration Outpatient Clinic. The highly purified ganglioside GTlb was generously provided by Fidia Research Laboratories, Abano Terme, Italy. Dr. Michael Pierschbacher of the La Jolla Cancer Foundation kindly provided the I1.5K fragment of human pFN containing the RGDS sequence and generated by chymotrypsin/pepsin treatments (35) .
Results
Purity of Fibronectin Fragments
The fragments of human plasma or cellular fibronectins to Figure 2 . Purity of fibronectin fragments. Human plasma or cellular fibronectins were purified and then proteolytically digested with thermolysin for affinity fractionation as described previously (8, I0) and in Materials and Methods. 10 Itg of each fragment class were applied to a gradient polyacrylamide gel containing SDS and a reducing agent for electrophoresis. The gel was then stained with Coomassie Blue for evaluation of patterns. Molecular weights are provided on the left side.
be used in these studies after thermolysin digestion and subsequent multiple affinity chromatographies are shown in Fig.  1 . The purity of these fragments was assessed by PAGE in the presence of SDS and a reducing agent (Fig. 2) . The two high molecular weight fragments (f145 and fl55) could be more readily resolved from each other by longer periods of electrophoresis and are derived from the r and i~-subunits of human pFN, respectively, as described previously (8, 10, 33) and differ by the latter's containing an additional type III homology unit and the former containing some IIICS sequence at its COOH terminus (five amino acids of IIICS [33] ) (Fig. 1 ). These fragments do not include the Arg-GluAsp-Val (REDV) functional domain recently discovered by Humphries et al. (20) . FII0 contains sequences shared in common by both subunits of human pFN around the RGDSdependent cell-binding domain and lacks any detectable heparin-binding activity when assayed as a soluble fragment. Also shown is a second cell-binding domain in these larger fragments that is RGDS-independent (48 and evidence below) and whose location has not been mapped precisely (its location in Fig. 1 is arbitrary) . In contrast, f38 and f29 contain the COOH-terminal heparin-binding domains of the two human pFN subunits but lack the RGDS-dependent and -independent cell-binding domains; they also differ with the former containing the additional type III homology unit and the latter possibly containing some IIICS sequence at its COOH terminus. These sequences are also shared with f44+47 from human cFN, which also contain the so-called
Concentration, ~g/ml Figure 3 . Adsorption of fibronectin fragments to the substratum evaluated by ELISA. 96-well tissue culture dishes were coated with 20 or 50 gg/ml of the indicated fibronectin fragments or with 1, 10, 20, or 50 txg/ml intact pFN for 1 h as described in Materials and Methods. Wells were then rinsed several times with PBS-II and postadsorbed with 250 ~tg/ml BSA in attachment medium for another hour. ELISA was then conducted using an antibody-excess amount of goat anti-pFN antiserum as described previously (28), followed by rabbit anti-goat alkaline phosphatase conjugate and p-nitrophenyl phosphate solution, with extensive rinsing between all steps. Optical density measurements were taken at 405 nm at t h and standard errors routinely fell within • % of the values shown.
"extra domaina" of the cellular fibronectins (Fig. 1) . The purity of these fragments is evident from these gel patterns with only minor contaminants evident in f44+47.
The effectiveness of binding of these fragments to the substratum was then evaluated quantitatively by enzyme-linked inununosorbent assay (ELISA) using methods described previously (28) . As shown in Fig. 3, intact pFN saturates the substratum at a concentration well below 10 gg/ml using polyclonal goat antibody to human pFN; the multiplicity of epitopes available for antibody binding is reflected in the higher maximum optical densities for pFN than those observed with any of the fragments (which reflect only subsets of the epitopes available in the whole molecule). Fragments fl55, f44+47, f38, and f29 saturate substratum sites below 20 ~tg/ml (i.e., 50 Ixg/ml fails to elicit higher antibody binding and reactivity than 20 I~g/ml). However, ill0 elicits somewhat more effective antibody binding at 50 lag/ml, and fl45 at this concentration doubles the amount of antibody-reactive material. These results demonstrate that, even though fl45 and f155 are very similar in size and sequence, the extra type III homology unit in fl55 leads to much more stable binding of this fragment on the substratum at a lower concentration.
Attachment Activity with Fibronectin Fragments
Adherence was tested on each fragment for comparison with similar data for intact human pFN and for human PF4 (27) . As shown in Fig. 4 using a concentration of 20 gg/ml for adsorption of all proteins, both Platt and La-N1 neuroblastoma cells attached poorly to the f29 univalent heparin-binding Fig. 5 . The concentration of fragments to achieve a maximal response was "~20 ~tg/ml (compared with 3-5 Ixg/ml for intact pFN) with the single exception of f145, consistent with the weaker binding of this particular fragment to the substratum (see Fig. 3 ). Also, the same data were obtained for either tissue culture plastic or glass substrata. These results indicate that there are differences in the attachment efficiency of cells on these fragments and that the sequences represented in the ED~ (e.g., by comparing f44+47 with either 129 or 138) and the extra type III homology repeat (e.g., by comparing 138 with 129) of the molecule can affect responses mediated by either the COOH-terminal heparin-binding domain or the RGDS-dependent cell-binding domain (by comparing fll0 with f145 or f155).
Effects upon Attachment by Medium-containing RGDS Peptide
It has been shown previously that some adhesion responses of cells are mediated by the RGDS-containing cell-binding domain of the fibronectin molecule which reacts with a 140K glycoprotein integrin complex (3, 9, 11, 19, 36, 37) . However, these human neuroblastoma cells (both Platt and La-N1) recognize at least two and possibly three different "cellbinding" activities on human pFN, only one of which is RGDS-dependent (31, 46, 48) . Therefore, it was important to assay these various fragments of pFN for the sensitivity of attachment of cells to RGDS-containing peptide (i.e., peptide A) when added in medium at the same time as cell inoculation. In all cases, the control peptide B (with a Glu substitution for the critical Asp residue) was without effect in these experiments (data not shown).
As shown in Fig. 6 , attachment to 138 was completely resistant to peptide A, which is expected since 138 lacks the RGDS-dependent cell-binding domain but does contain the heparin-binding domain. Of significance is the resistance of attachment of Platt cells to peptide A on fll0, which does contain the RGDS cell-binding domain but no heparinbinding activity when assayed in solution; these same preparations of peptide A inhibited attachment of BALB/c 3T3 cells at concentrations between 30 and 100 Ixg/ml. However, this fragment (fll0) has been shown to display a cryptic GAGbinding domain that becomes expressed when it binds to the substratum (28) and this may provide the basis for resistance to peptide A (see below for further analysis of this issue). In contrast, f145 demonstrated some sensitivity to peptide A and f155 was much more sensitive (Fig. 6) ; these fragments do contain the COOH-terminal heparin domain. The insensitivity on fll0 and the sensitivity on f155 to peptide A are identical for several preparations of the fragments; the same applies if fll0 and f155 are purified separately from the original thermolysin digest or if purified f155 is used as the sub- strate for protease digestion to obtain ill0. Therefore, a contaminant that co-purifies with one of the fragments is not a likely contributor to this differential sensitivity to peptide A. It would appear that inclusion of the heparin-binding domain in either of these fragments increases the dependence of attachment upon the RGDS cell-binding domain'. Since both of these fragments contain the same COOH-terminal heparin-binding domain, this differential response to f145 vs. f155 must be due to differences in sequence provided by the additional type III homology unit of f155 or the partial HICS sequences at the COOH terminus of f145. These results led to an experiment in which combinations of fragments on the substratum were tested for comparison with the individual fragments. As shown in the Untreated columns of Table I , substrata coated with an equal-weight combination of ill0 plus f38 (a mixture that represents virtually all the peptide sequence in f155) continued to be resistant to peptide A while f155 demonstrated significant sensitivity to peptide A (by Student's t-test, P < 0.005 for row 7, column 1 vs. column 2); raising or lowering the concentration of f38 did not change this result (data not shown). Also using a weight ratio of 3:1 of fl10/f38 which more approximates the equivalent molarities of the binding domains in the intact molecule, identical results were observed (not shown). Mixing of ill0 plus PF4 was also without effect (row 5, columns 1 and 2 in Table I ). Therefore, the covalently linked sequences in f155 contained in the additional type III homology unit are necessary to demonstrate this effect and mere addition of mixtures of fragments cannot reconstitute the effect. The same was observed when La-N1 cells were used in the same type of experiment.
In a similar experiment, cells were also pretreated with either chondroitinase ABC or Flavobacterium heparitanase under the same conditions used by Laterra et al. (27) to demonstrate that cell surface heparan sulfate proteoglycan does mediate certain adhesion responses of fibroblasts. This was done to test the relative contributions to these responses of the well-characterized COOH-terminal heparin-binding domain and a recently discovered cryptic GAG-binding domain, which maps close to the RGDS domain (28) . Table I illustrates that f38 and PF4 attachment processes are resistant to chondroitinase ABC but highly sensitive to heparitanase (by Student's t-test, P < 0.0005 for rows 1 or 2, columns 1 vs. 5), responses that are expected from these heparan sulfate-binding proteins. These results also demonstrate the effectiveness of enzymatic removal of cell surface heparan sulfates as shown previously (27) . However, under the same treatment conditions, attachment to ill0 remains resistant to either enzyme treatment (row 3, columns 1, 3, and 5) and to peptide A after the enzyme treatment (row 3, columns 2, 4, and 6). Therefore, the resistance of attachment to fll0 cannot be due to the cryptic GAG-binding domain in this fragment but must be attributed to a second "cellbinding" activity in the molecule located in these sequences (Fig. 1) or to much greater affinity of the RGDS sequence to its cell surface receptor. The same applies to substrata coated with a mixture of fll0 plus f38 (row 4). In contrast, * EGTA-detached and [3H]thymidine-radiolabeled Platt cells were rinsed twice in PBS with divalent cations and resuspended in the same solution supplemented with 2 mg/ml BSA. The suspended ceils were treated with chondroitinase ABC or Flavobacterium heparitanase as described in Laterra et al. (27) and in Materials and Methods; control cells were handled identically without the addition of any enzyme. Cells were then inoculated into plastic cluster dishes precoated with the indicated array of fibronectin fragments and/or PF4 at a total protein concentration of 20 rtg/ml; one set of wells contained 250 rtg/ml of peptide A (+ Pep A) while a second set of wells did not contain peptide A (-Pep A). After 1 h to allow cell attachment, unattached cells were rinsed out of the wells with PBS-containing divalent cations and the adherent cells assayed as described in Materials and Methods. The values presented are the percentages of the total number of cells inoculated into wells divided into the number of cells adherent (x 100). Errors for multiple samples of each fragment are standard errors. the mixture of ill0 plus PF4 becomes sensitive to heparitanase (by Student's t-test, P < 0.0005 for row 5, columns 1 vs. 5) but not to peptide A, demonstrating the dominance in this situation of the tetravalent heparan sulfate-binding activity of PF4 when acting as a supplement to the RGDSdependent cell-binding activity. While f145 displays little sensitivity to prior chondroitinase treatment of cells (row 6, columns 3 and 4), fl55 does display some (row 7, columns 3 and 4); in contrast, both f145 and fl55 display sensitivity to prior heparitanase treatment (row 5, columns 1 vs. 5, P < 0.005; row 7, columns 1 vs. 5, P < 0.025). Moreover, the enzyme treatment generates a resistance to peptide A not observed in the untreated control. This result suggests that cell surface heparan sulfate proteoglycan binding to the substratum ligand (specifically f155) increases the specific activity of the RGDS-dependent cell-binding domain.
Neurite Outgrowth on Fibronectin Fragments
On an appropriate substratum provided by more than one "cell-binding" activity of human pFN but not by its heparan sulfate-binding activity, Platt and La-N1 cells will generate neurites that have been characterized and quantitated previously using the intact pFN molecule (12, 31, 46, 48) . Therefore, fragments were tested for their ability to permit this "differentiation" response. As shown in Fig. 7 , a-c, the heparin-binding domain alone, as represented in the f29 or f38 fragments ofpFN or the f44+47 fragments ofcFN, were incompetent for neurite generation as expected from previous studies (46) ; cells only extended pseudopodial-like processes on these substrata without any evidence of a neurite fiber. In contrast, Platt cells on ill0 were able to generate neurites (broad arrowheads in Fig. 7 d) and only 40% of this activity was sensitive to peptide A but not to peptide B (Table  II, Table III . Even at 2 lxg/ml, intact pFN remains competent for inducing neurites while f155 or fll0 do not (P < 0.0005). However, significant attachment activity still occurs on fl55 or fll0 at this concentration. Of note is the difference (P < 0.005) at 10 lag/ml between fl55 and fll0 in specific activities for neurite formation. This might reflect the differing contributions of the RGDSdependent versus RGDS-independent cell-binding domains in the two fragments or, alternatively, different conformations of the two fragments on the substratum leading to very different affinities for the RGDS-dependent receptor.
Combinations of fragments were then tested for neurite generation. When equal amounts of f29 or f38 were mixed with ill0 before adsorbing the mixture to the substratum, some diminution of neurite outgrowth was observed, as well as some increase in the sensitivity to peptide A (Fig. 8, e and 3~ Table II , rows 4 and 5). In contrast, addition of the EDa sequences of cFN via f44 +47 did result in complete sensitivity to peptide A (Fig. 8, g and h and row 6 of Table II ). These results demonstrate that (a) the intact f145 and f155 fragments become modulated by these additional heparin-binding sequences far more effectively than mixtures of separate poly- * EGTA-detached Platt cells were inoculated into plastic cluster dishes precoated with indicated fibronectin fragment (total protein concentration of 20 I~g/ml). 250 I~g/ml of peptide A or B were added to the medium and the cells were allowed to attach for 18 h. They were then fixed with glutaraldehyde and scored for neurites. The values presented are the percentages of neurite-bearing cells divided by the total number of cells in the microscope field. When intact pFN is tested for comparison (data not shown), results virtually identical with fl 10 were observed. Standard errors and the numbers of observations (in parentheses) are included.
peptides and (b) the EDa sequences from cFN can modulate RGDS dependence more effectively than the pFN-derived sequences in f29 or f38. The same results were obtained for La-N1 cells. These experiments led to one in which fll0 was premixed with a varying concentration of f38 to determine the dose response (i.e., for f38) upon neurite generation mediated by ill0 and peptide A sensitivity of this process. ELISA data using antibodies directed toward each of these fragments have shown that either one of the fragments does not competitively displace the other fragment in binding to the substratum (Lewandowska, K., and L. A. Culp, manuscript submitted for publication), thereby verifying a true mixture of the two fragments on the substratum available to cell surface receptors. As shown in Table IV , neurite formation decreased significantly (P < 0.025) at a 1:1 weight ratio of fll0 and f38, and this was accompanied by increased peptide A sensitivity (ratio of +peptide/-peptide changing from 0.49 to 0.25). At a weight ratio of 1:3 (fl10/f38), neurite formation was one-third the maximal level and there was complete sensitivity to peptide A. Therefore, only higher concentrations of f38 reduce the ability of ill0 to induce neurites and associated with this reduction in the fraction of cells making * 48 well tissue culture dishes were coated with intact pFN, f155, or f110 at 2, 10, and 50 ~g/ml for 1 h. After postadsorption of all wells with 250 I.tg/ml BSA, Platt cells detached with EGTA and rinsed twice with attachment medium were inoculated at 25,000 cells per well. The cells were allowed to spread and make neurites for 18 h; they were then fixed with glutaraldehyde and scored for neurites. The numbers represent percent of neurite-bearing cells divided by total number of cells counted (given in parentheses). Six independent fields were examined in each case and standard errors are included. neurites is increased sensitivity to peptide A inhibition. This result contrasts with the complete inhibition of neurite formation of f155 alone on the substratum by peptide A at all concentrations of fl55. Peptide A was shown previously to "reverse" neurite formation (48), i.e., addition of peptide A to Platt or La-N1 cells that had already formed neurites on a chymotrypsingenerated 120K cell-binding fragment of pFN resulted in their complete dissolution within hours. A similar experiment was used here to test for the dynamics of neurite outgrowth based on the premise that continuously migrating neurites, mediated only by the RGDS-dependent cellbinding domain, would be sensitive to inhibition with peptide A whereas static, nonmoving neurites (or ones formed by an RGDS-independent mechanism) would be resistant to peptide A. A 24-h exposure to peptide A after 29 % of Platt cells had formed neurites on fll0 resulted in dissolution of two-thirds of these processes (Table V) with a P < 0.0005. This occurred at a concentration of peptide A of 250 lxg/ml, which was shown before to completely reverse formation on the RGDS-dependent 120K chymotrypsin cell-binding fragment (48) ; doubling the peptide A concentration resulted in only a slightly smaller neurite-containing fraction of cells (data not shown). In contrast, neurite formation on fl45 and fl55 was completely sensitive to reversal and mixtures of ill0 and f29 or f38 continued to show the partial sensitivity of fll0 alone (Table V) . Therefore, addition of a heparin-binding domain covalently linked, as represented in fl45 or f155, generated much greater sensitivity to peptide A, presumably by increasing the "specific activity" of the RGDS-dependent cell-binding activity; simple addition of separate fragments f38 or f29 to ill0 could not reconstitute this activity.
Discussion
The human neuroblastoma cells used here provide an ideal biological system for evaluating the functional activities of the fibronectin fragments. They attach and spread by pseudopodial extension on heparan sulfate-binding substrata, including PF4 as observed previously (46) and fibronectin fragments f29, f38, and f44+47 as observed in these studies. In contrast, they extend neurites that can be readily quantitated in the population when reacting with one or more cell-binding regions of the fibronectin molecule (46, 48) . It appears from the studies reported here that the second cellbinding activity of pFN (RGDS-independent) reported by Waite et al. (48) as contributing to neurite outgrowth can be found in the sequences of thermolysin-generated fragment fll0 that are not found in chymotrypsin-generated fragment f120, the CellH domain depicted in Fig. 1 , although its precise location is still arbitrary and may be due to distant sequences brought together by conformational folding. Adherence on fll0 is completely resistant to peptide A and this resistance cannot be reduced by chondroitinase or heparitinase pretreatments of the cells, indicating that a cryptic GAG-binding domain close to the RGDS cell-binding domain (28) is not responsible. Similarly, neurite outgrowth on ill0 is only partially sensitive to peptide A. Waite et al. (48) observed that both attachment and neurite outgrowth on a chymotrypsin-generated cell-binding fragment of pFN (120K) were completely sensitive to peptide A. This second activity is not due to ganglioside binding since supplementation of cells with GTlb, known to bind to the fibronectins (24, 45, 50, 51) and to effect human neuroblastoma adhesion on the appropriate substratum as reported previously (31, 48) , failed to alter responses of these cells (data not shown). Moreover, these studies suggest that neighboring sequences in some of these fragments alter fragment conformation on the substratum, thereby generating very different affinities for the 140K integrin receptor on the cell surface as well as a second "receptor y This would be reflected in differing sensitivities to the soluble RGDS peptide in the former case, and there is clearly some evidence for this (e.g., the different sensitivities of neurite formation on fl45 or fl55 to peptide A). In fact, all of the data reported here suggest that the RGDS-independent cell-binding activity is very sensitive to the conformation of fragments on the substratum, suggesting that this activity is not simple primary sequence in the polypeptide chain but results from two distant regions of sequence folding into proximity. Therefore, further cleavage of ill0 into smaller fragments and assay of RGDS-independent neurite promotion may or may not permit refined mapping of this activity.
A second nonganglioside or nonproteoglycan cell-binding activity has also been implicated in fibroblast adhesion studies with fibronectin by indirect evidence (6, 32, 47) . Also, Humphries et al. (20) have directly mapped a second RGDS-independent cell-binding domain to the alternately spliced IIICS region of the fibronectins. This activity is celltype specific for melanoma, is not effective for baby hamster kidney cells, and is dependent upon an REDV sequence in the IIICS region. A second cell-binding activity reported here for human neuroblastoma cells maps differently from the REDV domain; it is contained within fll0 which has no IIICS sequence (none of the fragments used in these studies contains an entire IIICS region with the REDV sequence [33] ). Therefore, there may be three cell-binding domains in the fibronectin molecule, only one of which is RGDSspecific and two of which may be cell-type specific. Further measurement of the dependence of adhesive responses of multiple cell types to these three binding domains should provide insight into the functional roles of three different "receptor" molecules in cells of developing embryos and in malignant cells during tumor progression.
The complexity of neuroblastoma interactions with the fibronectins reported here shares some findings with the results of McCarthy et al. (30) studying adherence and migration of melanoma cells on proteolytic fragments of human pFN. While a trypsin-generated 75K fragment mediated both attachment and motility of melanoma cells, a much smaller pepsin-generated ll.5K fragment facilitated RGDSdependent attachment but not motility. This suggested a second cell-binding domain in sequences not contained within the ll.5K fragment but contained within the 75K fragment responsible for migration. The results of neurite outgrowth on fll0 reported here are remarkably consistent with the melanoma studies of McCarthy et al. (30) . Furthermore, testing of the ll.5K pepsin fragment in the neuroblastoma system also failed to detect significant neurite outgrowth, a motility function on the substratum for a specialized region of the cell surface, while attachment on this fragment was completely RGDS sensitive (data not shown). Therefore, two tumor cell types of neuroectodermal origin, melanoma and neuroblastoma, may share multiple mechanisms of attachment and migration, with migration in the latter case being reflected in neurite outgrowth. These experiments have also revealed the significance of protein sequences neighboring known binding domains (particularly the extra type III homology unit) in the adhesive responses of human neuroblastoma cells. They also suggest, but certainly do not prove, that sequences generated by alternative splicing ofpre-messenger RNAs may modulate neighboring binding domains (21, 25, 34, 41) . The IIICS region can appear in multiple forms in cFN but in only two permutations in pFN (either with or without IIICS in the ~t-or 13-chains, respectively). Zardi and his collaborators (8, 10) took advantage of the simplicity of the latter system by isolating two complementary sets of fragments that differ in an additional type III homology unit from the ct-and 13-chains of human pFN, i.e., t29 vs. t38 and f145 vs. fl55 as displayed in Fig. 1. F145 and 129 contain five amino acids from the COOH terminus of the IIICS region as well (33) . In all experiments reported here, there are statistically significant differences in responses to the complementary fragments as summarized in Table VI . First, cells adhered much more effectively to f38 than f29. Second, attachment to f155 is much more sensitive to peptide A than attachment to fl45; since both fragments contain the COOH-terminal heparinbinding domain, this difference must be due to partial IIICS sequences of fl45 or the additional type III homology unit of f155. Therefore, these sequences can modulate the biological "specific activity" of the RGDS-dependent cell-binding activity. Third, only covalently linked sequences can modulate this attachment activity, which cannot be reconstituted by mixing of ill0 with 138 or 129. And, fourth, there are significant differences in neurite extension and sensitivity to this differentiation process by peptide A addition or by pretreatment of cells with GAG lyase (particularly heparitanase). Since the specific activities of these fragments are comparable and differences persist with fragments in the medium, it is unlikely that these differences result from differential binding stability on the substratum, and this is supported by the ELISA data of Fig. 3 .
One mechanism for the effects of the differing type III homology and IIICS sequences would be to affect the conformation of fragments bound to artificial glass or plastic substrata. This conclusion is supported by the requirement of covalently linked domains in modulation. That a conformational change can affect adhesion responses has been shown recently with human skin fibroblasts adhering and spreading more effectively on intact fibronectin that lacks asparaginelinked oligosaccharides when compared with fibronectin that is glycosylated (22) . Substratum-induced conformation changes would be expected to influence the affinity between the binding domain on the substratum and the cell surface receptor (32), as well as to affect accessibility of more than one cell surface ligand which would have a "cis" orientation on the surface of the cell (i.e., the two "receptors" are either bound to each other or, alternatively, are sufficiently close to effect cooperative interactions [31] ). Evidence for such cooperation is provided by two types of data in these studies. First, neurite formation on fl45 or f155 can be reversed with peptide A while formation on fll0 can only be partially reversed, revealing differential dependence on a second cellbinding domain. Second, pretreatment of cells with heparitanase results in attachment responses that are resistant to peptide A on fl55, a result that contrasts with the marked sensitivity to peptide A of control cultures. There appears to be some form of cooperative interaction between the heparan sulfate proteoglycan on the surface of these cells (29, 47a) and the RGDS-dependent receptor for fibronectin. Whether such a modulation could be effected on a natural collagenous substratum by these differing sequences remains to be determined.
In a couple of instances, effects upon adhesive responses were noted by the fragments carrying the so-called ED~ region of the cellular fibronectins as summarized in Table VI (21, 25, 43) . Attachment on f44+47 from cFN was intermediate between the very poor response to 129 and the good response to 138, both from pFN. Since all three fragment classes contain the same COOH-terminal heparin-binding domain, this difference of f44+47 with f29 or 138 must be due to the EDa region of the fragments. Furthermore, mixing of 138 with fll0 only affected the peptide A sensitivity of neurite outgrowth at high ratios of f38/fl10 and only as a consequence of diminished proportion of cells able to form neurites. This contrasted with the complete sensitivity of 1145 and f155 to peptide A and with the mixing of f44+47 with fll0 resulting in neurites sensitive to peptide A. These results would infer that EDa sequences can also affect the RGDSdependent cell-binding activity of the molecule, at least as far as fragment-mediated responses are concerned. Other experimental approaches, for example, using molecular biologically cloned individual and intact fibronectin polypeptides, will be required to determine whether EDa modulates binding reactions of the intact chains (42) .
The third category of modulation of cell-binding activities in these fragments derives from the contribution of the COOHterminal heparin-binding domain (Table VI) 
